Current and Emerging Treatment Options and Management of Duchenne Muscular Dystrophy

Author(s):

An expert on Duchenne muscular dystrophy reviews standard-of-care treatment options and provides clinical insights on adverse effects and safety concerns, particularly with corticosteroids.

EP: 1.Clinical Presentation and Diagnosis of Duchenne Muscular Dystrophy

EP: 2.Communication of Duchenne Muscular Dystrophy Diagnosis and Coordination of Care

Now Viewing

EP: 3.Current and Emerging Treatment Options and Management of Duchenne Muscular Dystrophy

EP: 4.Gene Therapy for Treatment of Duchenne Muscular Dystrophy

EP: 5.Targeting Pathways Downstream of Dystrophin: Vamorolone and Givinostat in Duchenne Muscular Dystrophy

EP: 6.Improvement in Management of Duchenne Muscular Dystrophy in Recent Years

EP: 7.Multidisciplinary Care in Duchenne Muscular Dystrophy

Video content above is prompted by the following questions:

Please briefly describe the current standard of care for Duchenne muscular dystrophy (DMD).
- What are the side effects and/or safety concerns associated with long-term use of corticosteroids in patients with DMD?
- Discuss recent approvals and ongoing studies in DMD.

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!